Linical Co. Faces Q1 Sales Dip Amid Market Contrasts
Company Announcements

Linical Co. Faces Q1 Sales Dip Amid Market Contrasts

Linical Co., Ltd. (JP:2183) has released an update.

Linical Co., Ltd. reports a consolidated net sales decrease of 5.0% in the first quarter of FY2025, compared to the previous year, due to significant market drops in Japan and Asia despite growth in the U.S. and Europe. The company has experienced an overall operating loss as gains in the U.S. and Europe were offset by losses in Japan and Asia.

For further insights into JP:2183 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App